Analysts at ICICI Securities believe the next two quarters will remain challenging for the cement industry as it will battle both weak demand (owing to monsoon) & heightened costs.
In current times of weak demand, high fuel costs and entry of a new player (Adani group), any significant capacity announcement may be viewed negatively by the market, according to analysts
CLOSING BELL: The Nifty IT index was the only gainer, up 0.45 per cent
Stocks to Watch: Aether Industries will be in focus as the speciality chemical maker is set to make its debut on the bourses today. The issue price has been fixed at Rs 642 per share.
This ambitious capacity expansion plan is a significant milestone in the ongoing transformational growth journey of UltraTech, says Kumar Mangalam Birla, chairman, Aditya Birla Group
The acquisition will make the Adani family the second biggest cement maker in India after Ultratech
Charts of steel stocks signal further downside, indicating a fall up to 20 per cent in select shares; cement counters indicate a wait-and-watch approach
Here are the top Business Standard headlines on Friday
Here are the top Business Standard headlines on Thursday
UltraTech outlines divestiture details that would meet the norms set by Competition Commission of India
Ebitda declined 16% YoY to Rs 3,165 cr, while Ebitda margins stood at 19.5% in Q4 versus 25.6% last year, as energy costs swelled in the period under review
Aditya Birla group firm UltraTech Cement Ltd on Friday reported an increase of 47.32 per cent in its consolidated net profit at Rs 2,613.75 crore in the fourth quarter ended March 2022
According to the technical analyst from Anand Rathi, Welcorp can rally towards Rs 240, whereas UltraTech can slide to Rs 6,400 in the coming weeks.
The block is situated in Tehsil Chittapur of Kalburgi district in Karnataka
Analysts believe current input cost headwinds are transitory as likely price hikes by companies will help aid margin pressures.
Despite these ongoing cost related challenges, demand outlook is expected to stay healthy from long-term perspective
Sun Pharma the biggest gainer among Sensex firms with a jump of 3.99 per cent, followed by TCS, NTPC, Wipro, Tech Mahindra, Dr Reddy's, UltraTech Cement and Infosys
The company is hopeful that cost inflation has peaked out and, with demand picking up, all of this should bolster volume growth and lead to margin rebound Q4 onwards.
As per Bloomberg estimates, the company's top line was seen at Rs 12,985 crore, while the bottom line was expected to be at Rs 1,494 crore in quarter ended December
Business Standard brings you the top headlines on Monday